Who owns InspireMD, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NSPR from SEC Form 13F filings across 37 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 37 institutions disclosed 21.5M shares of InspireMD, Inc. worth $15.1M — about 25.4% of shares outstanding; the largest disclosed holder is Rosalind Advisors, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
37
13F holders
$15.1M
value, 2026 filers
25.4%
of shares outstanding (21.5M sh)
7
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of NSPR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Rosalind Advisors, Inc. | 3.9M | $2.7M | 1.0% | 4.6% | 0.0% |
| 2 | Aberdeen Group plc | 3.7M | $2.6M | 0.0% | 4.4% | +16.5% |
| 3 | Nantahala Capital Management, LLC | 3.4M | $2.4M | 0.1% | 4% | 0.0% |
| 4 | ORBIMED ADVISORS LLC | 3.1M | $2.2M | 0.0% | 3.7% | 0.0% |
| 5 | Parkman Healthcare Partners LLC | 2.4M | $1.7M | 0.2% | 2.9% | 0.0% |
| 6 | MARSHALL WACE, LLP | 1.9M | $1.3M | 0.0% | 2.2% | 0.0% |
| 7 | Soleus Capital Management, L.P. | 1.0M | $732,100 | 0.0% | 1.2% | 0.0% |
| 8 | PURA VIDA INVESTMENTS, LLC | 450,517 | $315,407 | 0.9% | 0.5% | 0.0% |
| 9 | INGALLS & SNYDER LLC | 368,800 | $258,000 | 0.0% | 0.4% | -2.8% |
| 10 | Affiance Financial, LLC | 250,370 | $175,284 | 0.0% | 0.3% | 0.0% |
| 11 | Velan Capital Investment Management LP | 148,138 | $103,711 | 0.1% | 0.2% | -92.9% |
| 12 | BlackRock, Inc. | 122,993 | $86,108 | 0.0% | 0.1% | +52.9% |
| 13 | RENAISSANCE TECHNOLOGIES LLC | 112,832 | $78,994 | 0.0% | 0.1% | +540.8% |
| 14 | Creative Planning | 108,964 | $76,286 | 0.0% | 0.1% | +452.7% |
| 15 | Schonfeld Strategic Advisors LLCNEW | 99,275 | $69,502 | 0.0% | 0.1% | new |
| 16 | HRT FINANCIAL LPNEW | 59,754 | $41,000 | 0.0% | 0.1% | new |
| 17 | XTX Topco Ltd | 49,029 | $34,325 | 0.0% | 0.1% | +296.7% |
| 18 | Centiva Capital, LP | 44,123 | $30,891 | 0.0% | 0.1% | +78.2% |
| 19 | MILLENNIUM MANAGEMENT LLC | 37,677 | $26,378 | 0.0% | 0% | -66.5% |
| 20 | COURIER CAPITAL LLC | 30,000 | $21,003 | 0.0% | 0% | 0.0% |
| 21 | Mesirow Financial Investment Management, Inc. | 30,000 | $21,003 | 0.0% | 0% | 0.0% |
| 22 | MORGAN STANLEY | 28,371 | $19,863 | 0.0% | 0% | -28.8% |
| 23 | VESTIA PERSONAL WEALTH ADVISORS | 24,425 | $17,100 | 0.0% | 0% | 0.0% |
| 24 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 20,594 | $14,418 | 0.0% | 0% | new |
| 25 | Cambridge Investment Research Advisors, Inc.NEW | 20,166 | $14,000 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.